A survival analysis of the clinical breast cancer datasets indicated a strong correlation between higher FOSB expression and better relapse-free survival (RFS) (HR = 0.66, 95% CI 0.43–1.41, P = 0.056) (Fig. 2c) in TNBC. Here, FOSB is linked to breast cancer.